Study Condition(s): Adult Type 2 Diabetes

A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus (Award-10)

Study Alias: GBGE

Study Identifier(s): Tool Tip Icon {{ defaultRegistry.registryAnchorText }} NCT02597049 {{ currentLocaleObject.registryAnchorText }}

Completed Completed

Study Purpose

The main purpose of this study is to evaluate the efficacy and safety of the study drug known as dulaglutide when added to sodium-glucose co-transporter 2 (SGLT2) inhibitors in participants with type 2 diabetes mellitus

Completed Study

The results of this study are not yet available.

Who Participated? Tool Tip Icon

Here you can find out a bit more about the requirements for volunteers who took part in this study


Male Female


18+ years

Time Commitment

Your participation could last up to 38 weeks and include 11 visits to the study center
  • Participant must be diagnosed with type 2 diabetes mellitus (T2DM)

  • Participant must have been treated with an SGLT2 inhibitor, with or without metformin, for at least 3 months prior to study entry

  • Participant must agree to not initiate a diet and/or exercise program during the study with the intent of reducing body weight other than the lifestyle and dietary measures for diabetes treatment

  • Participant must not have type 1 diabetes mellitus

  • Participant must not have acute or chronic hepatitis or pancreatitis

Where This Study Took Place Tool Tip Icon

41 locations participated
Invalid Postal Code.
Please re-enter postal code.

{{sites.getPageStartCount()}} - {{sites.getPageEndCount()}} of {{sites.totalCount}} Results

0 of {{sites.totalCount}} Results

Distance Location
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
Closest Location
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
Other Location(s)
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}

To improve your experience on Lilly TrialGuide, please use the latest version of Chrome, Firefox, Safari, or Internet Explorer, with Java Script enabled.
This website is not optimized for your browser, as configured.